APG Asset Management N.V. Increases Stake in Waters Co. (WAT)

APG Asset Management N.V. lifted its stake in shares of Waters Co. (NYSE:WAT) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,835 shares of the medical instruments supplier’s stock after purchasing an additional 600 shares during the period. APG Asset Management N.V.’s holdings in Waters were worth $4,961,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the company. HighTower Advisors LLC lifted its position in shares of Waters by 1.0% during the second quarter. HighTower Advisors LLC now owns 2,280 shares of the medical instruments supplier’s stock worth $420,000 after purchasing an additional 23 shares in the last quarter. Intellectus Partners LLC lifted its position in shares of Waters by 4.9% during the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares in the last quarter. Advisory Services Network LLC lifted its position in shares of Waters by 6.0% during the second quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after purchasing an additional 65 shares in the last quarter. Linscomb & Williams Inc. lifted its position in shares of Waters by 3.7% during the second quarter. Linscomb & Williams Inc. now owns 2,494 shares of the medical instruments supplier’s stock worth $458,000 after purchasing an additional 90 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its position in shares of Waters by 3.0% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 6,668 shares of the medical instruments supplier’s stock worth $1,226,000 after purchasing an additional 196 shares in the last quarter. Institutional investors own 91.88% of the company’s stock.

In other Waters news, Director Thomas P. Salice sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $200.03, for a total value of $700,105.00. Following the completion of the sale, the director now owns 20,349 shares of the company’s stock, valued at $4,070,410.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joann A. Reed sold 1,386 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total transaction of $268,981.02. The disclosure for this sale can be found here. Insiders sold 124,789 shares of company stock valued at $26,083,647 in the last ninety days. Insiders own 5.07% of the company’s stock.

Shares of Waters Co. (WAT) opened at $203.26 on Tuesday. Waters Co. has a 12 month low of $144.66 and a 12 month high of $220.20. The company has a quick ratio of 1.97, a current ratio of 2.10 and a debt-to-equity ratio of 0.66. The company has a market cap of $16,170.00, a P/E ratio of 1,129.22, a price-to-earnings-growth ratio of 2.54 and a beta of 0.88.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The firm had revenue of $687.28 million during the quarter, compared to the consensus estimate of $671.98 million. During the same quarter in the prior year, the firm earned $2.21 earnings per share. The business’s quarterly revenue was up 9.3% on a year-over-year basis. equities research analysts forecast that Waters Co. will post 8.16 EPS for the current fiscal year.

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. upped their target price on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 24th. William Blair reissued an “outperform” rating on shares of Waters in a research note on Tuesday, January 23rd. BTIG Research reissued a “buy” rating on shares of Waters in a research note on Thursday, January 25th. Citigroup boosted their price target on shares of Waters from $190.00 to $223.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 24th. Finally, Barclays boosted their price target on shares of Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 24th. Twelve analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Waters currently has an average rating of “Hold” and a consensus price target of $203.75.

TRADEMARK VIOLATION NOTICE: This article was posted by Stock Observer and is the property of of Stock Observer. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thestockobserver.com/2018/02/06/apg-asset-management-n-v-increases-stake-in-waters-co-wat.html.

Waters Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply